Outset Medical OM
$ 0.89
-0.6%
Annual report 2023
added 02-21-2024
Outset Medical Balance Sheet 2011-2024 | OM
Annual Balance Sheet Outset Medical
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
63.2 M | 24.4 M | -151 M | -286 M | -7.86 M | 105 M | - | - | - | - | - | - | - |
Long Term Debt |
130 M | 96.3 M | 29.8 M | 8.04 M | 21.6 M | 28.3 M | - | - | - | - | - | - | - |
Long Term Debt Current |
1.59 M | 1.32 M | 1.15 M | 882 K | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 436 M | 429 M | - | - | - | - | - | - | - |
Total Current Liabilities |
55.3 M | 51.9 M | 51.7 M | 36.7 M | - | - | - | - | - | - | - | - | - |
Total Liabilities |
191 M | 154 M | 89.4 M | 75.2 M | 461 M | 439 M | - | - | - | - | - | - | - |
Deferred Revenue |
11.7 M | 8.66 M | 6.34 M | 3.2 M | 883 K | 269 K | - | - | - | - | - | - | - |
Retained Earnings |
-962 M | -789 M | -626 M | - | -373 M | -288 M | - | - | - | - | - | - | - |
Total Assets |
314 M | 400 M | 463 M | 404 M | 88.4 M | 151 M | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
68.5 M | 73.2 M | 182 M | 295 M | 36.9 M | - | - | - | - | - | - | - | - |
Book Value |
123 M | 246 M | 374 M | 329 M | -372 M | -288 M | - | - | - | - | - | - | - |
Total Shareholders Equity |
123 M | 246 M | 374 M | 329 M | -372 M | -288 M | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Outset Medical
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | 29.8 M | 29.8 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 29.7 M | 21.6 M | 21.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | 86.3 M | 89.4 M | 79.1 M | 73.7 M | 73.2 M | 75.2 M | 75.2 M | 75.2 M | 75.2 M | 51.1 M | 51.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | 6.83 M | 6.34 M | 5.21 M | 4.37 M | 3.54 M | 3.2 M | 3.2 M | 3.2 M | 3.2 M | 883 K | 883 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
- | - | - | -663 M | -626 M | -585 M | -554 M | -524 M | -494 M | -494 M | -494 M | -494 M | -373 M | -373 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
- | - | - | 432 M | 463 M | 489 M | 505 M | 380 M | 404 M | 404 M | 404 M | 404 M | 88.4 M | 88.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
- | - | - | 114 M | 182 M | 231 M | 274 M | 252 M | 295 M | 295 M | 295 M | 295 M | 36.9 M | 36.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
- | - | - | 345 M | 374 M | 410 M | 431 M | 307 M | 329 M | 329 M | 329 M | 329 M | 37.3 M | 37.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
- | - | - | 345 M | 374 M | 410 M | 431 M | 307 M | 329 M | 329 M | 329 M | 329 M | -372 M | -372 M | -336 M | -312 M | -288 M | - | - | - | -216 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency